These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23943021)

  • 21. Oncological benefit of metformin in patients with pancreatic ductal adenocarcinoma and comorbid diabetes mellitus.
    Terasaki F; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
    Langenbecks Arch Surg; 2020 May; 405(3):313-324. PubMed ID: 32367394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension.
    Bachellier P; Rosso E; Fuchshuber P; Addeo P; David P; Oussoultzoglou E; Lucescu I
    Surgery; 2014 Mar; 155(3):449-56. PubMed ID: 24462078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system.
    Rochefort MM; Ankeny JS; Kadera BE; Donald GW; Isacoff W; Wainberg ZA; Hines OJ; Donahue TR; Reber HA; Tomlinson JS
    Ann Surg Oncol; 2013 Dec; 20(13):4322-9. PubMed ID: 23943022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of long-term survivors after surgical resection for pancreatic cancer.
    Han SS; Jang JY; Kim SW; Kim WH; Lee KU; Park YH
    Pancreas; 2006 Apr; 32(3):271-5. PubMed ID: 16628082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival.
    Marangos IP; Buanes T; Røsok BI; Kazaryan AM; Rosseland AR; Grzyb K; Villanger O; Mathisen Ø; Gladhaug IP; Edwin B
    Surgery; 2012 May; 151(5):717-23. PubMed ID: 22284762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.
    Strobel O; Hartwig W; Hackert T; Hinz U; Berens V; Grenacher L; Bergmann F; Debus J; Jäger D; Büchler M; Werner J
    Ann Surg Oncol; 2013 Mar; 20(3):964-72. PubMed ID: 23233235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
    Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
    J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis.
    Walter U; Kohlert T; Rahbari NN; Weitz J; Welsch T
    Ann Surg Oncol; 2014 Apr; 21(4):1082-9. PubMed ID: 24322532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative complications deteriorate long-term outcome in pancreatic cancer patients.
    Kamphues C; Bova R; Schricke D; Hippler-Benscheidt M; Klauschen F; Stenzinger A; Seehofer D; Glanemann M; Neuhaus P; Bahra M
    Ann Surg Oncol; 2012 Mar; 19(3):856-63. PubMed ID: 21879265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term survival after surgical resection for pancreatic cancer.
    Yoshizawa K; Nagai H; Kurihara K; Sata N; Kawai T; Saito K
    Hepatogastroenterology; 2001; 48(40):1153-6. PubMed ID: 11490822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
    Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
    Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection.
    Cannon RM; LeGrand R; Chagpar RB; Ahmad SA; McClaine R; Kim HJ; Rupp C; Cho CS; Brinkman A; Weber S; Winslow ER; Kooby DA; Chu CK; Staley CA; Glenn I; Hawkins WG; Parikh AA; Merchant NB; McMasters KM; Martin RC; Callender GG; Scoggins CR
    HPB (Oxford); 2012 Apr; 14(4):228-35. PubMed ID: 22404260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma.
    An W; Ben QW; Chen HT; Zheng JM; Huang L; Li GX; Li ZS
    Ann Surg Oncol; 2012 Nov; 19(12):3971-8. PubMed ID: 22622471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
    Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
    Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of pancreatic adenocarcinoma tumor staging and resection according to previous body mass index and diabetes duration.
    Souza JJ; Machado MC; Cunha JE; Jukemura J; Nery M; Wajchenberg BL; Pereira MA; Corrêa-Giannella ML; Giannella-Neto D
    Pancreatology; 2007; 7(2-3):187-93. PubMed ID: 17592233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.